Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium

被引:10
作者
Bernstein, Cheryl D. [1 ]
Albrecht, Kara L. [1 ]
Marcus, Dawn A. [2 ]
机构
[1] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15206 USA
[2] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15237 USA
关键词
antidepressant; depression; fatigue; serotonin-norepinephrine reuptake inhibitor; weight loss; NORADRENALINE REUPTAKE INHIBITOR; DOUBLE-BLIND; THERAPEUTIC RESPONSE; CLINICAL-TRIAL; RAT MODEL; SEROTONIN; PLACEBO; ANTIDEPRESSANTS; PAIN; PREGABALIN;
D O I
10.1517/14656566.2013.779670
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Antidepressants are used to treat a variety of chronic pain conditions including peripheral neuropathy, headache, and more recently, fibromyalgia. The antidepressant milnacipran blocks the reuptake of norepinephrine and serotonin and is used for the management of fibromyalgia. Areas covered: The article contains data primarily obtained from the MEDLINE database using a PubMed search of the keywords including milnacipran, fibromyalgia and depression. Of the available serotonin norepinephrine reuptake inhibitors, milnacipran has greater potency in inhibiting reuptake of norepinephrine relative to serotonin and is proposed to work by attenuating pain signals. Milnacipran is well tolerated and effective for fibromyalgia pain when given in divided doses of 100 - 200 mg daily. Studies show that milnacipran may be effective for fibromyalgia-associated symptoms including depression and fatigue. Expert opinion: Milnacipran provides modest fibromyalgia pain relief and is best used as part of a multidisciplinary treatment approach. While milnacipran was not studied in fibromyalgia patients with major depression, it may be a wise choice for fibromyalgia patients with depressive symptoms and patients for whom sedation, dizziness, edema or weight gain with gabapentin and pregabalin is a problem. Milnacipran has been found to be beneficial for treating some troublesome fibromyalgia-associated symptoms, including fatigue and cognitive dysfunction.
引用
收藏
页码:905 / 916
页数:12
相关论文
共 82 条
[1]   QTc Intervals in Drug Poisoning Patients with Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors [J].
Acikalin, Ayca ;
Satar, Salim ;
Avci, Akkan ;
Topal, Metin ;
Kuvandik, Gueven ;
Sebe, Ahmet .
AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (01) :30-33
[2]  
Alp R, 2008, EUR REV MED PHARMACO, V12, P223
[3]   Citalopram in patients with fibromyalgia - a randomized, double blind, placebo-controlled study [J].
Anderberg, UM ;
Marteinsdottir, I ;
von Knorring, L .
EUROPEAN JOURNAL OF PAIN-LONDON, 2000, 4 (01) :27-35
[4]  
Arnold L, 2011, J PAIN S2, V12, pS22
[5]   Patient perspectives on the impact of fibromyalgia [J].
Arnold, Lesley M. ;
Crofford, Leslie J. ;
Mease, Philip J. ;
Burgess, Somali Misra ;
Palmer, Susan C. ;
Abetz, Linda ;
Martin, Susan A. .
PATIENT EDUCATION AND COUNSELING, 2008, 73 (01) :114-120
[6]   Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial [J].
Arnold, Lesley M. ;
Goldenberg, Don L. ;
Stanford, Sharon B. ;
Lalonde, Justine K. ;
Sandhu, H. S. ;
Keck, Paul E., Jr. ;
Welge, Jeffrey A. ;
Bishop, Fred ;
Stanford, Kevin E. ;
Hess, Evelyn V. ;
Hudson, James I. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1336-1344
[7]   Effect of milnacipran on body weight in patients with fibromyalgia [J].
Arnold, Lesley M. ;
Palmer, Robert H. ;
Hufford, Michael R. ;
Chen, Wei .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2012, 5 :879-887
[8]   Efficacy and Safety of Milnacipran 100 mg/day in Patients With Fibromyalgia [J].
Arnold, Lesley M. ;
Gendreau, R. Michael ;
Palmer, Robert H. ;
Gendreau, Judy F. ;
Wang, Yong .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2745-2756
[9]   Antidepressant treatment of fibromyalgia : A meta-analysis and review [J].
Arnold, LM ;
Keck, PE ;
Welge, JA .
PSYCHOSOMATICS, 2000, 41 (02) :104-113
[10]  
Arnold LM, 2009, ARTHRITIS RHEUM S, V60, P1422